nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.152	0.213	CbGbCtD
Halofantrine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.146	0.205	CbGbCtD
Halofantrine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0696	0.098	CbGbCtD
Halofantrine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0638	0.0898	CbGbCtD
Halofantrine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0636	0.0895	CbGbCtD
Halofantrine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0614	0.0863	CbGbCtD
Halofantrine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0591	0.0832	CbGbCtD
Halofantrine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0272	0.0382	CbGbCtD
Halofantrine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0267	0.0375	CbGbCtD
Halofantrine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0249	0.035	CbGbCtD
Halofantrine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.017	0.0239	CbGbCtD
Halofantrine—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000845	0.00292	CcSEcCtD
Halofantrine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000842	0.00291	CcSEcCtD
Halofantrine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000839	0.0029	CcSEcCtD
Halofantrine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000839	0.0029	CcSEcCtD
Halofantrine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000837	0.00289	CcSEcCtD
Halofantrine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000835	0.00289	CcSEcCtD
Halofantrine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000832	0.00288	CcSEcCtD
Halofantrine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000827	0.00286	CcSEcCtD
Halofantrine—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000822	0.00284	CcSEcCtD
Halofantrine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000815	0.00282	CcSEcCtD
Halofantrine—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000812	0.00281	CcSEcCtD
Halofantrine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000809	0.0028	CcSEcCtD
Halofantrine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000809	0.0028	CcSEcCtD
Halofantrine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000809	0.0028	CcSEcCtD
Halofantrine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000805	0.00279	CcSEcCtD
Halofantrine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000802	0.00278	CcSEcCtD
Halofantrine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000802	0.00278	CcSEcCtD
Halofantrine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000797	0.00276	CcSEcCtD
Halofantrine—Abnormal vision—Epirubicin—peripheral nervous system neoplasm	0.000795	0.00275	CcSEcCtD
Halofantrine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000795	0.00275	CcSEcCtD
Halofantrine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00079	0.00273	CcSEcCtD
Halofantrine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000786	0.00272	CcSEcCtD
Halofantrine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000782	0.0027	CcSEcCtD
Halofantrine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00078	0.0027	CcSEcCtD
Halofantrine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00078	0.0027	CcSEcCtD
Halofantrine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000776	0.00268	CcSEcCtD
Halofantrine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000776	0.00268	CcSEcCtD
Halofantrine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000776	0.00268	CcSEcCtD
Halofantrine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000776	0.00268	CcSEcCtD
Halofantrine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000776	0.00268	CcSEcCtD
Halofantrine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000769	0.00266	CcSEcCtD
Halofantrine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000766	0.00265	CcSEcCtD
Halofantrine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000765	0.00264	CcSEcCtD
Halofantrine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000761	0.00263	CcSEcCtD
Halofantrine—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000751	0.0026	CcSEcCtD
Halofantrine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00075	0.00259	CcSEcCtD
Halofantrine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000748	0.00259	CcSEcCtD
Halofantrine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000744	0.00257	CcSEcCtD
Halofantrine—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.000736	0.00255	CcSEcCtD
Halofantrine—Chills—Etoposide—peripheral nervous system neoplasm	0.000733	0.00254	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000731	0.00253	CcSEcCtD
Halofantrine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00072	0.00249	CcSEcCtD
Halofantrine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000717	0.00248	CcSEcCtD
Halofantrine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00071	0.00245	CcSEcCtD
Halofantrine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000709	0.00245	CcSEcCtD
Halofantrine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000704	0.00244	CcSEcCtD
Halofantrine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000704	0.00244	CcSEcCtD
Halofantrine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.0007	0.00242	CcSEcCtD
Halofantrine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0007	0.00242	CcSEcCtD
Halofantrine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000697	0.00241	CcSEcCtD
Halofantrine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000695	0.0024	CcSEcCtD
Halofantrine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000694	0.0024	CcSEcCtD
Halofantrine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000694	0.0024	CcSEcCtD
Halofantrine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000692	0.00239	CcSEcCtD
Halofantrine—Back pain—Etoposide—peripheral nervous system neoplasm	0.000688	0.00238	CcSEcCtD
Halofantrine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000685	0.00237	CcSEcCtD
Halofantrine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000683	0.00236	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000678	0.00234	CcSEcCtD
Halofantrine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000677	0.00234	CcSEcCtD
Halofantrine—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000676	0.00234	CcSEcCtD
Halofantrine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000673	0.00233	CcSEcCtD
Halofantrine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000671	0.00232	CcSEcCtD
Halofantrine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000671	0.00232	CcSEcCtD
Halofantrine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000668	0.00231	CcSEcCtD
Halofantrine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000663	0.00229	CcSEcCtD
Halofantrine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000661	0.00229	CcSEcCtD
Halofantrine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000661	0.00229	CcSEcCtD
Halofantrine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00066	0.00228	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000656	0.00227	CcSEcCtD
Halofantrine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.00226	CcSEcCtD
Halofantrine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000654	0.00226	CcSEcCtD
Halofantrine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000653	0.00226	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000653	0.00226	CcSEcCtD
Halofantrine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000649	0.00224	CcSEcCtD
Halofantrine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000649	0.00224	CcSEcCtD
Halofantrine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000646	0.00224	CcSEcCtD
Halofantrine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000643	0.00223	CcSEcCtD
Halofantrine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000641	0.00222	CcSEcCtD
Halofantrine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.00222	CcSEcCtD
Halofantrine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000639	0.00221	CcSEcCtD
Halofantrine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000636	0.0022	CcSEcCtD
Halofantrine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000634	0.00219	CcSEcCtD
Halofantrine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000634	0.00219	CcSEcCtD
Halofantrine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000629	0.00218	CcSEcCtD
Halofantrine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.00216	CcSEcCtD
Halofantrine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000624	0.00216	CcSEcCtD
Halofantrine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000624	0.00216	CcSEcCtD
Halofantrine—Rash—Topotecan—peripheral nervous system neoplasm	0.000624	0.00216	CcSEcCtD
Halofantrine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000623	0.00216	CcSEcCtD
Halofantrine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000623	0.00215	CcSEcCtD
Halofantrine—Cough—Etoposide—peripheral nervous system neoplasm	0.000621	0.00215	CcSEcCtD
Halofantrine—Headache—Topotecan—peripheral nervous system neoplasm	0.00062	0.00214	CcSEcCtD
Halofantrine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000619	0.00214	CcSEcCtD
Halofantrine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000619	0.00214	CcSEcCtD
Halofantrine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000618	0.00214	CcSEcCtD
Halofantrine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000618	0.00214	CcSEcCtD
Halofantrine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000618	0.00214	CcSEcCtD
Halofantrine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000616	0.00213	CcSEcCtD
Halofantrine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000616	0.00213	CcSEcCtD
Halofantrine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000615	0.00213	CcSEcCtD
Halofantrine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000615	0.00213	CcSEcCtD
Halofantrine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000613	0.00212	CcSEcCtD
Halofantrine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000613	0.00212	CcSEcCtD
Halofantrine—Rash—Melphalan—peripheral nervous system neoplasm	0.000611	0.00211	CcSEcCtD
Halofantrine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00061	0.00211	CcSEcCtD
Halofantrine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000608	0.0021	CcSEcCtD
Halofantrine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000606	0.00209	CcSEcCtD
Halofantrine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000605	0.00209	CcSEcCtD
Halofantrine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000604	0.00209	CcSEcCtD
Halofantrine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000598	0.00207	CcSEcCtD
Halofantrine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.00205	CcSEcCtD
Halofantrine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000591	0.00204	CcSEcCtD
Halofantrine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000588	0.00203	CcSEcCtD
Halofantrine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000588	0.00203	CcSEcCtD
Halofantrine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000586	0.00203	CcSEcCtD
Halofantrine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000585	0.00202	CcSEcCtD
Halofantrine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000583	0.00202	CcSEcCtD
Halofantrine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000583	0.00202	CcSEcCtD
Halofantrine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000581	0.00201	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000577	0.002	CcSEcCtD
Halofantrine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000576	0.00199	CcSEcCtD
Halofantrine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000575	0.00199	CcSEcCtD
Halofantrine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000575	0.00199	CcSEcCtD
Halofantrine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000569	0.00197	CcSEcCtD
Halofantrine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000567	0.00196	CcSEcCtD
Halofantrine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.00194	CcSEcCtD
Halofantrine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000553	0.00191	CcSEcCtD
Halofantrine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000551	0.00191	CcSEcCtD
Halofantrine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000549	0.0019	CcSEcCtD
Halofantrine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000534	0.00185	CcSEcCtD
Halofantrine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.00184	CcSEcCtD
Halofantrine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000529	0.00183	CcSEcCtD
Halofantrine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000526	0.00182	CcSEcCtD
Halofantrine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000522	0.00181	CcSEcCtD
Halofantrine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000521	0.0018	CcSEcCtD
Halofantrine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000514	0.00178	CcSEcCtD
Halofantrine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00051	0.00176	CcSEcCtD
Halofantrine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000509	0.00176	CcSEcCtD
Halofantrine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000506	0.00175	CcSEcCtD
Halofantrine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000505	0.00175	CcSEcCtD
Halofantrine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.0005	0.00173	CcSEcCtD
Halofantrine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000497	0.00172	CcSEcCtD
Halofantrine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000496	0.00172	CcSEcCtD
Halofantrine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.0017	CcSEcCtD
Halofantrine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00049	0.0017	CcSEcCtD
Halofantrine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.00169	CcSEcCtD
Halofantrine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000478	0.00165	CcSEcCtD
Halofantrine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000476	0.00165	CcSEcCtD
Halofantrine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000475	0.00164	CcSEcCtD
Halofantrine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000474	0.00164	CcSEcCtD
Halofantrine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000473	0.00164	CcSEcCtD
Halofantrine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.00162	CcSEcCtD
Halofantrine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00162	CcSEcCtD
Halofantrine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000466	0.00161	CcSEcCtD
Halofantrine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000461	0.00159	CcSEcCtD
Halofantrine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00159	CcSEcCtD
Halofantrine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000459	0.00159	CcSEcCtD
Halofantrine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000456	0.00158	CcSEcCtD
Halofantrine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000455	0.00157	CcSEcCtD
Halofantrine—Rash—Vincristine—peripheral nervous system neoplasm	0.000452	0.00156	CcSEcCtD
Halofantrine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000451	0.00156	CcSEcCtD
Halofantrine—Headache—Vincristine—peripheral nervous system neoplasm	0.000449	0.00155	CcSEcCtD
Halofantrine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.00153	CcSEcCtD
Halofantrine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00153	CcSEcCtD
Halofantrine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000434	0.0015	CcSEcCtD
Halofantrine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000427	0.00148	CcSEcCtD
Halofantrine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000426	0.00147	CcSEcCtD
Halofantrine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000417	0.00144	CcSEcCtD
Halofantrine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000411	0.00142	CcSEcCtD
Halofantrine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000411	0.00142	CcSEcCtD
Halofantrine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000409	0.00142	CcSEcCtD
Halofantrine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00141	CcSEcCtD
Halofantrine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000403	0.00139	CcSEcCtD
Halofantrine—Rash—Cisplatin—peripheral nervous system neoplasm	0.0004	0.00138	CcSEcCtD
Halofantrine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000399	0.00138	CcSEcCtD
Halofantrine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000397	0.00137	CcSEcCtD
Halofantrine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.00137	CcSEcCtD
Halofantrine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000386	0.00133	CcSEcCtD
Halofantrine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000384	0.00133	CcSEcCtD
Halofantrine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.00132	CcSEcCtD
Halofantrine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.00131	CcSEcCtD
Halofantrine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000376	0.0013	CcSEcCtD
Halofantrine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00128	CcSEcCtD
Halofantrine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000369	0.00128	CcSEcCtD
Halofantrine—Rash—Etoposide—peripheral nervous system neoplasm	0.000366	0.00127	CcSEcCtD
Halofantrine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000366	0.00126	CcSEcCtD
Halofantrine—Headache—Etoposide—peripheral nervous system neoplasm	0.000364	0.00126	CcSEcCtD
Halofantrine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00124	CcSEcCtD
Halofantrine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.00123	CcSEcCtD
Halofantrine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000352	0.00122	CcSEcCtD
Halofantrine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000348	0.0012	CcSEcCtD
Halofantrine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00119	CcSEcCtD
Halofantrine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000345	0.00119	CcSEcCtD
Halofantrine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.00118	CcSEcCtD
Halofantrine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00117	CcSEcCtD
Halofantrine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00117	CcSEcCtD
Halofantrine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00117	CcSEcCtD
Halofantrine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000335	0.00116	CcSEcCtD
Halofantrine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.00115	CcSEcCtD
Halofantrine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000328	0.00113	CcSEcCtD
Halofantrine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.00113	CcSEcCtD
Halofantrine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000325	0.00113	CcSEcCtD
Halofantrine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.00111	CcSEcCtD
Halofantrine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00111	CcSEcCtD
Halofantrine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.00109	CcSEcCtD
Halofantrine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.00109	CcSEcCtD
Halofantrine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.00109	CcSEcCtD
Halofantrine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00107	CcSEcCtD
Halofantrine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00107	CcSEcCtD
Halofantrine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.00105	CcSEcCtD
Halofantrine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.00104	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000296	0.00103	CcSEcCtD
Halofantrine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00101	CcSEcCtD
Halofantrine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000993	CcSEcCtD
Halofantrine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000991	CcSEcCtD
Halofantrine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000978	CcSEcCtD
Halofantrine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000281	0.00097	CcSEcCtD
Halofantrine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000962	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000949	CcSEcCtD
Halofantrine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000935	CcSEcCtD
Halofantrine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000927	CcSEcCtD
Halofantrine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00092	CcSEcCtD
Halofantrine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000917	CcSEcCtD
Halofantrine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000905	CcSEcCtD
Halofantrine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000898	CcSEcCtD
Halofantrine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000894	CcSEcCtD
Halofantrine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000891	CcSEcCtD
Halofantrine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000257	0.00089	CcSEcCtD
Halofantrine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000858	CcSEcCtD
Halofantrine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000852	CcSEcCtD
Halofantrine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000827	CcSEcCtD
Halofantrine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000823	CcSEcCtD
Halofantrine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000807	CcSEcCtD
Halofantrine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000796	CcSEcCtD
Halofantrine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00077	CcSEcCtD
Halofantrine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000747	CcSEcCtD
Halofantrine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000744	CcSEcCtD
Halofantrine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000737	CcSEcCtD
Halofantrine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000716	CcSEcCtD
Halofantrine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000712	CcSEcCtD
Halofantrine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00071	CcSEcCtD
Halofantrine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000709	CcSEcCtD
Halofantrine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000705	CcSEcCtD
Halofantrine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000689	CcSEcCtD
Halofantrine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000668	CcSEcCtD
Halofantrine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000662	CcSEcCtD
Halofantrine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000657	CcSEcCtD
Halofantrine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000656	CcSEcCtD
Halofantrine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000652	CcSEcCtD
Halofantrine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000619	CcSEcCtD
